Antidiabetic 99% Raw Powder Linagliptin CAS 668270-12-0 CAS NO.668270-12-0

We promise our customers the following items

1. Reasonable price
We provide high-quality products at competitive prices in china.

2. Good and efficient service, Fast Delivery
Fast response save client's time, we promise to reply inquiry within 24 hours including holidays and send quotation sheets and other documents in 48 hours.

3. Super-good quality
We have a strict quality control system. Good reputation in the Market.

4. Packing
We can do it according to the customers' request.

5. Transport
The products can be transported  by Courier, by air or by sea

6. Service
We offer specialized logistic service including export declaration, customs clearance, and every detail during shipment, this makes us able to provide you with one-stop service from the order to the products transported to your hand.

Linagliptin, also known as BI-1356, is a DPP-4 inhibitor developed by Boehringer Ingelheim for treatment of type II diabetes. Linagliptin (once-daily) was approved by the US FDA on 2 May 2011 for treatment of type II diabetes. It is being marketed by Boehringer Ingelheim and Lilly.

Application
 
Linagliptin  is a kind of dipeptide peptidase 4 (DPP - 4) inhibitors used as dietary and exercise in type 2 diabetes in adult auxiliary treatment to improve blood sugar control.

Linagliptin is used with a proper diet and exercise program and possibly with othermedications to control high blood sugar. It is used by people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.

99% CAS 668270-12-0 Linagliptin Ondero for Type 2 Diabetes

Functions

 1. Incretin (Incretin) has the role of intestinal promoting insuli n B cells to secrete insuli n, mainly including glucose-dependent insuli notropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1). DDP-4 is a serine protease located on the cell surface, which is widely found in plasma and in vivo tissues (such as kidney, liver, small intestine villi, endothelial cells, etc.). Rilalitine is a selective DPP-4 inhibitor that inhibits the activity of the enzyme by reversibly binding to DPP-4, delays GLP-1 degradation, enhances GLP-1 activity, and stimulates glucose-dependent Insuli n secretion, and reduce circulating levels of glucagon, thereby regulating blood glucose levels in patients with type 2 diabetes.

2. Compared with other DPP-4 inhibitors, the main advantages of liradetine is: with excellent renal safety, and can effectively reduce glycosylated hemoglobin. Lilardine mainly in the form of excretion of fecal excretion, the oral administration, the amount of renal excretion is only 5% of the dose, even if the intravenous administration, and only 30.8% of the excretion by the kidney, so the patient did not need treatment Regularly check the liver, kidney function and dose adjustment, all patients can be a unified fixed dose, easy to prescribe.

Packaging

FAQ

1.Can I get some samples
Yes, usually a 10-20g sample.

2.What's your MOQ
Our MOQ is flexible, usually 1kg-10kg for a trial order is acceptable.

3. Is there a discount
Of course, welcome to contact us. Price would be different based on different quantities. For bulk quantity, we will have a discount for you.

4. How to deliver the goods
≤50kg ship by FedEx or DHL etc, ≥50kg ship by Air, ≥100kg can be shipped by Sea. If you have special request on delivery, please contact us.

5. What is the shelf life for the products
Most products shelf life 24-36 months. 

6. What's your delivery time
Usually, shipment will be made within 7-15 days against confirmed order.

7. How about the validity of the offer 
Usually, our offer is valid for 1 week. However, validity might vary between different products.